| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | 4,6,10-Trioxa-5-phosphaoctacos-19-enoic acid, 2-amino-5-hydroxy-11-oxo-8-[(1-oxohexadecyl)oxy]-, 5-oxide, sodium salt (1:1), (2S,8R,19Z)- Basic information |
| Product Name: | 4,6,10-Trioxa-5-phosphaoctacos-19-enoic acid, 2-amino-5-hydroxy-11-oxo-8-[(1-oxohexadecyl)oxy]-, 5-oxide, sodium salt (1:1), (2S,8R,19Z)- | | Synonyms: | 4,6,10-Trioxa-5-phosphaoctacos-19-enoic acid, 2-amino-5-hydroxy-11-oxo-8-[(1-oxohexadecyl)oxy]-, 5-oxide, sodium salt (1:1), (2S,8R,19Z)-;Sodium (S)-2-amino-2-carboxyethyl ((R)-3-(oleoyloxy)-2-(palmitoyloxy)propyl) phosphate;18:1(n9)- 16:0 PS - IsoPure;18:1(n9)-16:0 PS - IsoPure sodium | | CAS: | 2389048-56-8 | | MF: | C40H77NNaO10P | | MW: | 786.02 | | EINECS: | | | Product Categories: | | | Mol File: | 2389048-56-8.mol | ![4,6,10-Trioxa-5-phosphaoctacos-19-enoic acid, 2-amino-5-hydroxy-11-oxo-8-[(1-oxohexadecyl)oxy]-, 5-oxide, sodium salt (1:1), (2S,8R,19Z)- Structure](CAS/20210111/GIF/2389048-56-8.gif) |
| | 4,6,10-Trioxa-5-phosphaoctacos-19-enoic acid, 2-amino-5-hydroxy-11-oxo-8-[(1-oxohexadecyl)oxy]-, 5-oxide, sodium salt (1:1), (2S,8R,19Z)- Chemical Properties |
| storage temp. | -20°C | | form | chloroform solution | | Major Application | lipidomics
metabolomics | | InChIKey | QKPXXPNOIWGYEJ-JEAFVVATSA-M | | SMILES | [H][C@@](COP([O-])(OC[C@](C([O-])=O)([H])[NH3+])=O)(OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+] |
| WGK Germany | WGK 3 | | Storage Class | 6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects | | Hazard Classifications | Acute Tox. 3 Inhalation
Acute Tox. 4 Oral
Carc. 2
Eye Irrit. 2
Repr. 2
Skin Irrit. 2
STOT RE 1 Oral
STOT SE 3 |
| | 4,6,10-Trioxa-5-phosphaoctacos-19-enoic acid, 2-amino-5-hydroxy-11-oxo-8-[(1-oxohexadecyl)oxy]-, 5-oxide, sodium salt (1:1), (2S,8R,19Z)- Usage And Synthesis |
| Uses | Glycerophospholipids act as regulators of various enzyme activities, and can be used as biological markers to indicate pathological states. |
| | 4,6,10-Trioxa-5-phosphaoctacos-19-enoic acid, 2-amino-5-hydroxy-11-oxo-8-[(1-oxohexadecyl)oxy]-, 5-oxide, sodium salt (1:1), (2S,8R,19Z)- Preparation Products And Raw materials |
|
|
Tag:4,6,10-Trioxa-5-phosphaoctacos-19-enoic acid, 2-amino-5-hydroxy-11-oxo-8-[(1-oxohexadecyl)oxy]-, 5-oxide, sodium salt (1:1), (2S,8R,19Z)-(2389048-56-8)
Related Product Information
|